John Byrd, M.D.
Project Involvement: Project 6 - Pharmacology
Dr. John Byrd is the Director of the Hematologic Malignancies Program at Ohio State University. His research interests focus on experimental therapeutics in hematologic cancers. Dr. Byrd currently heads several novel studies of promising new agents in the treatment of Chronic Lymphocytic Leukemia. He has earned numerous awards, including the 2000 Colonel William Crosby Superiority in Research Award.
D. Warren Brown Professor of Leukemia Research
Interim Co-Director, Division of Hematology and Oncology,
Department of Internal Medicine
Associate Director for Translational Research
The Comprehensive Cancer Center
Arthur G. James Cancer Hospital
Faculty Title: Professor of Medicine and Medicinal Chemistry
Specialty Interests: Hematologic malignancies; Waldenstrom's Macroglobulinemia
Research Interests: Experimental therapeutics